Los Angeles Capital Management LLC Neurocrine Biosciences Inc Transaction History
Los Angeles Capital Management LLC
- $26.1 Billion
- Q2 2025
A detailed history of Los Angeles Capital Management LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 744,650 shares of NBIX stock, worth $96 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
744,650
Previous 3,808
19454.88%
Holding current value
$96 Million
Previous $421,000
22131.59%
% of portfolio
0.36%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding NBIX
# of Institutions
656Shares Held
101MCall Options Held
282KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$1.83 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.26 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$718 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$576 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$398 Million0.04% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.3B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...